Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Ocular surface tissue hydration" refers to the physiological state in which the tissues covering the front part of the eye—primarily the cornea and conjunctiva—are adequately moistened by tears. This is essential for maintaining optical clarity, protecting against environmental insults, supporting epithelial healing, and preventing frictional damage from blinking. The process depends on several factors including tear production by lacrimal glands, mucin secretion by goblet cells in the conjunctiva, lipid layer integrity from meibomian glands reducing evaporation, and active fluid transport across corneal endothelium via ion pumps. Disruption in any component can lead to dry eye disease or other forms of ocular discomfort and pathology such as filamentary keratitis. While many drugs aim to enhance or restore this function—such as artificial tears or anti-inflammatory agents—the term itself does not refer to a discrete molecular entity but rather an emergent property resulting from multiple biological systems working together[2][3]. There is no single molecule/receptor named "Ocular surface tissue hydration," so it should not be considered a canonical therapeutic target. If you are seeking information about specific molecules involved in regulating this process—such as aquaporins, sodium-potassium ATPase pumps on endothelial cells,[2] mucins,[3] etc.—please specify further. In summary: **"Ocular surface tissue hydration" is not a molecular target but describes an important physiological condition maintained by multiple cellular processes at the front of the eye.[1][2][3]**
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular surface tissue hydration.